ANGELA SANU: Open Payments
NPI 1821503012 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,707 in 34 payments from 14 companies in 2025. Trend: 2023 $752 · 2024 $1,644 · 2025 $1,707
Food & beverage: $1,707
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $457 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $186 |
| Alkermes, Inc. | 4 | $159 |
| Boston Scientific Corporation | 1 | $142 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| ACADIA Pharmaceuticals Inc | 1 | $122 |
| KYOWA KIRIN, INC. | 1 | $121 |
| Amarin Pharma, Inc. | 1 | $113 |
| Neurocrine BioSciences, Inc. | 5 | $98 |
| CVRx, Inc. | 1 | $89 |
Products named: AUSTEDO XR, CAPLYTA, WATCHMAN FLX, Auvelity, DAYBUE, CRYSVITA, LYBALVI, Vascepa.
Industry payments across TX — which companies pay providers there.
